EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Long-term results of dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring using a gimbal-mounted linac for liver tumors: a multicenter observational study

Yusuke Iizuka, Minoru Inoue, Masaki Kokubo, Takashi Sakamoto, Keiko Nemoto Murofushi, Toshiyuki Imagumbai, Takuya Shimizuguchi, Masahiro Hiraoka, Takashi Mizowaki

International Journal of Clinical Oncology · 2025

DOI: 10.1007/s10147-025-02740-2 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Clinical Oncology, 2025. Verfasst von Yusuke Iizuka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Medicine, Department of Radiation Oncology and Image-Applied Therapy, Kyoto University, Kyoto, Kyoto, Japan. yiizuka@kuhp.kyoto-u.…. Hauptthemen laut MEDLINE: Radiosurgery, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Despite advancements in liver tumor treatments, a persistent need remains for minimally invasive therapies with high efficacy and long-term outcomes. In a previous multicenter phase II study, the safety and efficacy of dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors were evaluated using a gimbal-mounted system. Herein, we report the updated long-term results of this technique. METHODS: This observational study examined patients with a single liver tumor, respiratory movement of at least 10 mm, performance status of 0-2, and Child-Pugh score of < 9. Patients who agreed to participate in the trial underwent dynamic tumor-tracking stereotactic body radiotherapy (prescribed dose, 40 Gy in five fractions for the planning target volume [D95]; 70% of the maximum dose). The primary endpoint was the 4-year overall survival rate. Secondary endpoints included 4-year local control and progression-free survival rates and the incidence of adverse events. RESULTS: Between September 2015 and March 2019, 48 patients (median age, 74 years; median tumor diameter, 17.5 mm) underwent dynamic tumor-tracking stereotactic body radiotherapy. All lesions were successfully treated (hepatocellular carcinoma, 39 patients; liver metastases, 9 patients). The median observation period was 46 months, and the 4-year overall survival, local control, and progression-free survival rates were 67.4%, 97.9%, and 29.1%, respectively. Eight patients had grade 3 hepatobiliary enzyme elevation, hematologic toxicity, or hyponatremia; none had grade ≥ 4 adverse events. CONCLUSION: These findings demonstrate the long-term safety and efficacy of dynamic tumor-tracking stereotactic body radiotherapy for liver tumors, with an excellent local control rate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryLiver NeoplasmsCarcinoma, HepatocellularHumansAgedMaleFemaleMiddle AgedAged, 80 and overTreatment Outcome

Stichwörter der Autor:innen

Dynamic tumor trackingHepatocellular carcinomaLiverMetastasisStereotactic body radiotherapy

Autor:innen und Institutionen

  • Graduate School of Medicine, Department of Radiation Oncology and Image-Applied Therapy, Kyoto University, Kyoto, Kyoto, Japan. yiizuka@kuhp.kyoto-u.ac.jp.
  • Department of Radiation Oncology, Shizuoka City Shizuoka Hospital, Shizuoka, Shizuoka, Japan. yiizuka@kuhp.kyoto-u.ac.jp.
  • Graduate School of Medicine, Department of Radiation Oncology and Image-Applied Therapy, Kyoto University, Kyoto, Kyoto, Japan.
  • Department of Radiation Oncology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
  • Department of Radiation Oncology, Kyoto Katsura Hospital, Kyoto, Kyoto, Japan.
  • Division of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo, Tokyo, Japan.

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Iizuka, Y., Inoue, M., Kokubo, M., Sakamoto, T., Murofushi, K. N., Imagumbai, T., Shimizuguchi, T., Hiraoka, M., & Mizowaki, T. (2025). Long-term results of dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring using a gimbal-mounted linac for liver tumors: a multicenter observational study. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-025-02740-2

Vancouver

Iizuka Y, Inoue M, Kokubo M, Sakamoto T, Murofushi KN, Imagumbai T, et al. Long-term results of dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring using a gimbal-mounted linac for liver tumors: a multicenter observational study. International Journal of Clinical Oncology. 2025. doi:10.1007/s10147-025-02740-2

BibTeX
@article{Iizuka2025,
  author = {Iizuka, Yusuke and Inoue, Minoru and Kokubo, Masaki and Sakamoto, Takashi and Murofushi, Keiko Nemoto and Imagumbai, Toshiyuki and Shimizuguchi, Takuya and Hiraoka, Masahiro and Mizowaki, Takashi},
  title = {Long-term results of dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring using a gimbal-mounted linac for liver tumors: a multicenter observational study},
  journal = {International Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1007/s10147-025-02740-2}
}
Kostenlos starten →